Crossref
Evaluating the Long-Term Outcomes of Medical and Surgical Treatments in Fibrostenotic Crohn’s Disease Patients Treated with Anti-TNF/Biologic Therapy
Experimed · 2022
DOI: 10.26650/experimed.1183920 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimed, 2022. Verfasst von Çağatay Ak und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ak, Ç., Sayar, S., Kahraman, R., & Özdil, K. (2022). Evaluating the Long-Term Outcomes of Medical and Surgical Treatments in Fibrostenotic Crohn’s Disease Patients Treated with Anti-TNF/Biologic Therapy. Experimed. https://doi.org/10.26650/experimed.1183920
Vancouver
Ak Ç, Sayar S, Kahraman R, Özdil K. Evaluating the Long-Term Outcomes of Medical and Surgical Treatments in Fibrostenotic Crohn’s Disease Patients Treated with Anti-TNF/Biologic Therapy. Experimed. 2022. doi:10.26650/experimed.1183920
BibTeX
@article{Ak2022,
author = {Ak, Çağatay and Sayar, Süleyman and Kahraman, Resul and Özdil, Kamil},
title = {Evaluating the Long-Term Outcomes of Medical and Surgical Treatments in Fibrostenotic Crohn’s Disease Patients Treated with Anti-TNF/Biologic Therapy},
journal = {Experimed},
year = {2022},
doi = {10.26650/experimed.1183920}
}
EUVIMED